Isthmus Partners LLC decreased its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 3.6% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 39,566 shares of the company’s stock after selling 1,477 shares during the period. Becton, Dickinson and Company makes up about 2.2% of Isthmus Partners LLC’s holdings, making the stock its 6th largest position. Isthmus Partners LLC’s holdings in Becton, Dickinson and Company were worth $6,864,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in BDX. Nisa Investment Advisors LLC raised its stake in shares of Becton, Dickinson and Company by 3.7% in the second quarter. Nisa Investment Advisors LLC now owns 82,585 shares of the company’s stock valued at $14,005,000 after buying an additional 2,930 shares during the period. LS Investment Advisors LLC raised its stake in Becton, Dickinson and Company by 7.9% in the second quarter. LS Investment Advisors LLC now owns 25,574 shares of the company’s stock valued at $4,337,000 after buying an additional 1,877 shares during the last quarter. Checchi Capital Advisers LLC raised its stake in Becton, Dickinson and Company by 0.8% in the second quarter. Checchi Capital Advisers LLC now owns 1,786 shares of the company’s stock valued at $303,000 after buying an additional 14 shares during the last quarter. CIBC World Markets Inc. raised its stake in Becton, Dickinson and Company by 256.3% in the second quarter. CIBC World Markets Inc. now owns 52,442 shares of the company’s stock valued at $8,894,000 after buying an additional 37,723 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its stake in Becton, Dickinson and Company by 2.2% in the second quarter. Robeco Institutional Asset Management B.V. now owns 293,956 shares of the company’s stock valued at $49,852,000 after buying an additional 6,226 shares during the last quarter. Hedge funds and other institutional investors own 81.18% of the company’s stock.

Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Shares of Becton, Dickinson and Company (NYSE:BDX) traded down 0.34% during mid-day trading on Friday, hitting $172.90. 170,757 shares of the company were exchanged. The company has a market capitalization of $36.71 billion, a price-to-earnings ratio of 38.51 and a beta of 1.00. Becton, Dickinson and Company has a 12-month low of $129.50 and a 12-month high of $181.76. The firm has a 50 day moving average of $167.40 and a 200 day moving average of $172.31.

Becton, Dickinson and Company (NYSE:BDX) last released its earnings results on Thursday, November 3rd. The company reported $2.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.09 by $0.03. Becton, Dickinson and Company had a return on equity of 24.45% and a net margin of 7.82%. The firm had revenue of $3.23 billion for the quarter, compared to analysts’ expectations of $3.22 billion. During the same quarter in the previous year, the business posted $1.94 earnings per share. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. Equities research analysts forecast that Becton, Dickinson and Company will post $9.47 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 30th. Shareholders of record on Friday, December 9th were given a $0.73 dividend. This represents a $2.92 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date was Wednesday, December 7th. This is a boost from Becton, Dickinson and Company’s previous quarterly dividend of $0.66. Becton, Dickinson and Company’s payout ratio is currently 64.75%.

TRADEMARK VIOLATION WARNING: This story was originally posted by Watch List News and is the propert of of Watch List News. If you are reading this story on another website, it was stolen and republished in violation of U.S. & international copyright & trademark law. The correct version of this story can be viewed at http://www.watchlistnews.com/becton-dickinson-and-company-bdx-position-cut-by-isthmus-partners-llc/1059909.html.

BDX has been the topic of several analyst reports. Citigroup Inc. lowered shares of Becton, Dickinson and Company from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $167.00 to $165.00 in a report on Friday, September 23rd. Zacks Investment Research lowered shares of Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a report on Wednesday, November 16th. Argus reaffirmed a “buy” rating and issued a $185.00 target price on shares of Becton, Dickinson and Company in a report on Friday, October 21st. Leerink Swann reaffirmed a “market perform” rating and issued a $185.00 target price (up previously from $180.00) on shares of Becton, Dickinson and Company in a report on Monday, November 21st. Finally, Raymond James Financial, Inc. reaffirmed an “outperform” rating and issued a $180.00 target price (down previously from $200.00) on shares of Becton, Dickinson and Company in a report on Thursday, January 5th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $176.39.

In other news, insider Stephen Sichak sold 10,352 shares of the business’s stock in a transaction dated Friday, November 4th. The stock was sold at an average price of $176.10, for a total transaction of $1,822,987.20. Following the sale, the insider now directly owns 26,892 shares in the company, valued at $4,735,681.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP John E. Gallagher sold 1,793 shares of the business’s stock in a transaction dated Thursday, December 15th. The stock was sold at an average price of $168.82, for a total value of $302,694.26. Following the sale, the vice president now owns 2,796 shares in the company, valued at $472,020.72. The disclosure for this sale can be found here. 1.40% of the stock is owned by company insiders.

About Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

5 Day Chart for NYSE:BDX

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.